Combining SNA with anti-PD1 regulated innate immune cells, slowed OS tumor growth and prolonged survival time of tumor-bearing mice via inhibiting the function of MDSCs with a selective PI3Kδ/γ inhibitor to enhance responses to immune checkpoint blockade. This evidence concerns the gene PDCD1 and neoplasm.